Welcome to Ypsomed

Ypsomed is a worldwide leading independent developer and manufacturer of injection systems for custom-made self-administration and supplier of pen needles for the treatment of diabetes, growth disorders or infertility, as well as for further therapeutic areas. Ypsomed has well-established partnerships with numerous leading pharmaceutical and biotech companies such as Sanofi-Aventis, Eli Lilly, Pfizer, Roche, Genentech, Merck Serono, Amylin, NPS and others.

Ypsomed is headquartered in Burgdorf, Switzerland, and employs over 1200 employees at several production sites in Switzerland and throughout a European sales and distribution network.